Subject to change.
Subject to change.
Esther Abels, CEO of SolarisRTC, is a visionary leader challenging the status quo to accelerate patient access to innovation. With 27+ years of expertise in IVD, Quality, Regulatory, Clinical & Pharma, she pioneers digital & computational pathology, translating research into clinical practice and shaping global healthcare pathways.
FDA - DPA collaboration announcement. Join industry leaders and vendors for an open, collaborative townhall focused on advancing digital pathology regulatory science, developing open-source tools, and fostering vendor-neutral, efficient technical assessment - while ensuring fairness, transparency, and broad participation across the digital pathology ecosystem.
**PathVisions25 registration required.
FDA - DPA collaboration announcement. Join industry leaders and vendors for an open, collaborative townhall focused on advancing digital pathology regulatory science, developing open-source tools, and fostering vendor-neutral, efficient technical assessment - while ensuring fairness, transparency, and broad participation across the digital pathology ecosystem.
**PathVisions25 registration required.
FDA - DPA collaboration announcement. Join industry leaders and vendors for an open, collaborative townhall focused on advancing digital pathology regulatory science, developing open-source tools, and fostering vendor-neutral, efficient technical assessment - while ensuring fairness, transparency, and broad participation across the digital pathology ecosystem.
**PathVisions25 registration required.
FDA - DPA collaboration announcement. Join industry leaders and vendors for an open, collaborative townhall focused on advancing digital pathology regulatory science, developing open-source tools, and fostering vendor-neutral, efficient technical assessment - while ensuring fairness, transparency, and broad participation across the digital pathology ecosystem.
**PathVisions25 registration required.